Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josh Knowland

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Nuclear Medicine Technology|August 25, 2018
Practical Clinical Measurement of Radiotracer Concentration in Blood: Initial Device Concept and Feasibility TestingJosh Knowland, Ronald Lattanze, Jesse Kingg, et al.
EJNMMI Physics|September 14, 2022
Development of a classifier for [18F]fluorodeoxyglucose extravasation severity using semi-quantitative readings from topically applied detectorsSteve Perrin, Jackson W Kiser, Josh Knowland, et al.
Health Physics|July 15, 2022
Practical Tools for Patient-specific Characterization and Dosimetry of Radiopharmaceutical ExtravasationSean Wilson, Dustin Osborne, Misty Long, et al.
Health Physics|January 14, 2021
Patient-specific Extravasation Dosimetry Using Uptake Probe MeasurementsDustin Osborne, Jackson W Kiser, Josh Knowland, et al.
Medical Physics|April 12, 2019
Technical Note: Characterization of technology to detect residual injection site radioactivityJosh Knowland, Samantha Lipman, Ron Lattanze, et al.
Frontiers in Medicine|July 15, 2021
The Scientific and Clinical Case for Reviewing Diagnostic Radiopharmaceutical Extravasation Long-Standing AssumptionsDustin Osborne, Ronald Lattanze, Josh Knowland, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Nuclear Medicine Technology|August 25, 2018
Practical Clinical Measurement of Radiotracer Concentration in Blood: Initial Device Concept and Feasibility TestingJosh Knowland, Ronald Lattanze, Jesse Kingg, et al.
EJNMMI Physics|September 14, 2022
Development of a classifier for [18F]fluorodeoxyglucose extravasation severity using semi-quantitative readings from topically applied detectorsSteve Perrin, Jackson W Kiser, Josh Knowland, et al.
Health Physics|July 15, 2022
Practical Tools for Patient-specific Characterization and Dosimetry of Radiopharmaceutical ExtravasationSean Wilson, Dustin Osborne, Misty Long, et al.
Health Physics|January 14, 2021
Patient-specific Extravasation Dosimetry Using Uptake Probe MeasurementsDustin Osborne, Jackson W Kiser, Josh Knowland, et al.
Medical Physics|April 12, 2019
Technical Note: Characterization of technology to detect residual injection site radioactivityJosh Knowland, Samantha Lipman, Ron Lattanze, et al.
Frontiers in Medicine|July 15, 2021
The Scientific and Clinical Case for Reviewing Diagnostic Radiopharmaceutical Extravasation Long-Standing AssumptionsDustin Osborne, Ronald Lattanze, Josh Knowland, et al.
Pageof 1